New Double-Action PET tracer aims to sharpen cancer detection
NCT ID NCT07639801
First seen Jun 12, 2026 · Last updated Jun 15, 2026 · Updated 1 time
Summary
This early study will test a new type of PET scan that uses two targets (FAPI and PSMA) at once to find and stage solid tumors like prostate, liver, ovarian, and endometrial cancers. About 20 adults with suspected or confirmed tumors will get this new scan, and doctors will compare it to standard scans to see if it picks up more tumors or gives clearer images. The goal is to improve how accurately cancer is detected and staged, which could help guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.